The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis

• Published in: Mediators of Inflammation Vol. 2014; no. 5; pp. 397 - 415
• Main Authors: Wojdasiewicz, Piotr, Szukiewicz, Dariusz, Poniatowski, Łukasz A.
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Limiteds 01.01.2014; Hindawi Publishing Corporation; John Wiley & Sons, Inc; Wiley
• Subjects: Animals; Anti-Inflammatory Agents - chemistry; Cytokines; Cytokines - metabolism; Health aspects; Humans; Immunologic Factors - chemistry; Inflammation; Inflammation - physiopathology; Interleukin-15 - metabolism; Interleukin-17 - metabolism; Interleukin-18 - metabolism; Interleukin-1beta - metabolism; Interleukin-4 - metabolism; Interleukin-6 - metabolism; Joint Diseases - physiopathology; Mice; Osteoarthritis; Osteoarthritis - immunology; Osteoarthritis - physiopathology; Physiological aspects; Review; Signal Transduction; Tumor Necrosis Factor-alpha - metabolism
• ISSN: 0962-9351; 1466-1861; 1466-1861
• DOI: 10.1155/2014/561459

Osteoarthritis (OA) is the most common chronic disease of human joints. The basis of pathologic changes involves all the tissues forming the joint; already, at an early stage, it has the nature of inflammation with varying degrees of severity. An analysis of the complex relationships indicates that the processes taking place inside the joint are not merely a set that (seemingly) only includes catabolic effects. Apart from them, anti-inflammatory anabolic processes also occur continually. These phenomena are driven by various mediators, of which the key role is attributed to the interactions within the cytokine network. The most important group controlling the disease seems to be inflammatory cytokines, including IL-1β, TNFα, IL-6, IL-15, IL-17, and IL-18. The second group with antagonistic effect is formed by cytokines known as anti-inflammatory cytokines such as IL-4, IL-10, and IL-13. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of OA with respect to inter- and intracellular signaling pathways is still under investigation. This paper summarizes the current state of knowledge. The cytokine network in OA is put in the context of cells involved in this degenerative joint disease. The possibilities for further implementation of new therapeutic strategies in OA are also pointed.